Health
Neuropilin-1: A new route of SARS-CoV-2 entry – News-Medical.Net
A new study published in the reputed journal Science in October 2020 reports the potential therapeutic value of the second type of host transmembrane receptor,…
Researchers have long established that the binding of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) to the host angiotensin-converting enzyme 2 (ACE2) is essential for the virus to gain entry to and infect the host cell. A new study published in the reputed journal Sciencein October 2020 reports the potential therapeutic value of the second type of host transmembrane receptor, called neuropilins, which attach to the spike protein of SARS-CoV-2 and may enhance its infectivity.
In this…
-
Business14 hours agoBattle of the ASX ETFs: Why has VGS outperformed VTS this year?
-
Business10 hours ago1 ASX dividend stock down 43% I’d buy right now
-
General20 hours agoCoalition abandons ‘end’ to work from home, walks back 41,000 job cuts
-
General18 hours agoFrench far-right supporters rally against Le Pen conviction in Paris